IN2014CN04050A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04050A IN2014CN04050A IN4050CHN2014A IN2014CN04050A IN 2014CN04050 A IN2014CN04050 A IN 2014CN04050A IN 4050CHN2014 A IN4050CHN2014 A IN 4050CHN2014A IN 2014CN04050 A IN2014CN04050 A IN 2014CN04050A
- Authority
- IN
- India
- Prior art keywords
- arylglucosides
- useful
- building block
- present
- provides processes
- Prior art date
Links
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161556780P | 2011-11-07 | 2011-11-07 | |
| US201261661793P | 2012-06-19 | 2012-06-19 | |
| PCT/IB2012/002894 WO2013068850A2 (fr) | 2011-11-07 | 2012-11-07 | Procédé pour la préparation de β-c-arylglucosides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04050A true IN2014CN04050A (fr) | 2015-07-10 |
Family
ID=48290709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4050CHN2014 IN2014CN04050A (fr) | 2011-11-07 | 2012-11-07 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2776449B1 (fr) |
| JP (1) | JP6144686B2 (fr) |
| KR (1) | KR101756772B1 (fr) |
| CN (1) | CN103974964B (fr) |
| AU (1) | AU2012335280B2 (fr) |
| BR (1) | BR112014010997A2 (fr) |
| CA (1) | CA2854591A1 (fr) |
| IL (1) | IL232418A (fr) |
| IN (1) | IN2014CN04050A (fr) |
| TW (1) | TWI488861B (fr) |
| WO (1) | WO2013068850A2 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104557894A (zh) * | 2013-10-18 | 2015-04-29 | 上海信谊药厂有限公司 | 坎格列汀晶型及其制备方法 |
| WO2015155739A1 (fr) * | 2014-04-11 | 2015-10-15 | Scinopharm Taiwan, Ltd. | Procédé pour la préparation de beta-c-arylglucosides |
| CN105017237A (zh) * | 2014-04-29 | 2015-11-04 | 嘉实（湖南）医药科技有限公司 | 一种卡格列净的制备工艺 |
| EP2947077A1 (fr) | 2014-05-19 | 2015-11-25 | LEK Pharmaceuticals d.d. | Synthèse stéréosélective d'intermédiaires dans la préparation de ß-C-arylglucosides |
| US10370365B2 (en) | 2015-09-16 | 2019-08-06 | Optimus Drugs (P) Limited | Process for the preparation of Canagliflozin |
| CN105294624B (zh) * | 2015-11-16 | 2018-01-12 | 山东罗欣药业集团股份有限公司 | 一种达格列净的制备方法 |
| CN105486767B (zh) * | 2015-12-03 | 2018-03-13 | 上海应用技术学院 | 一种达格列净及其α‑异构体的分离方法 |
| CN105541815B (zh) * | 2015-12-24 | 2018-07-13 | 寿光富康制药有限公司 | 一种卡格列净的制备方法 |
| EP4114365A1 (fr) | 2020-03-05 | 2023-01-11 | KRKA, d.d., Novo mesto | Composition pharmaceutique comprenant un inhibiteur du sglt2 |
| EP4161912A1 (fr) | 2020-06-05 | 2023-04-12 | KRKA, d.d., Novo mesto | Préparation de dapagliflozine amorphe très pure |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5872599A (ja) * | 1981-10-27 | 1983-04-30 | Kanto Ishi Pharma Co Ltd | 複合糖質誘導体 |
| EP1581543A4 (fr) * | 2003-01-03 | 2008-03-19 | Bristol Myers Squibb Co | Procedes de production d'inhibiteurs de c-aryle glucoside sglt2 |
| AR056195A1 (es) * | 2005-09-15 | 2007-09-26 | Boehringer Ingelheim Int | Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos |
| WO2011064726A1 (fr) | 2009-11-24 | 2011-06-03 | South African Medical Research Council | Procédé de synthèse d'aspalathine et de ses analogues |
-
2012
- 2012-11-07 CA CA2854591A patent/CA2854591A1/fr not_active Abandoned
- 2012-11-07 IN IN4050CHN2014 patent/IN2014CN04050A/en unknown
- 2012-11-07 EP EP12847376.6A patent/EP2776449B1/fr not_active Not-in-force
- 2012-11-07 AU AU2012335280A patent/AU2012335280B2/en not_active Ceased
- 2012-11-07 KR KR1020147015420A patent/KR101756772B1/ko not_active Expired - Fee Related
- 2012-11-07 BR BR112014010997A patent/BR112014010997A2/pt not_active Application Discontinuation
- 2012-11-07 JP JP2014539427A patent/JP6144686B2/ja not_active Expired - Fee Related
- 2012-11-07 WO PCT/IB2012/002894 patent/WO2013068850A2/fr not_active Ceased
- 2012-11-07 TW TW101141390A patent/TWI488861B/zh not_active IP Right Cessation
- 2012-11-07 CN CN201280054691.2A patent/CN103974964B/zh not_active Expired - Fee Related
-
2014
- 2014-05-01 IL IL232418A patent/IL232418A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2776449A4 (fr) | 2015-10-07 |
| CN103974964B (zh) | 2016-03-23 |
| AU2012335280B2 (en) | 2016-09-29 |
| JP6144686B2 (ja) | 2017-06-07 |
| BR112014010997A2 (pt) | 2017-06-06 |
| WO2013068850A2 (fr) | 2013-05-16 |
| WO2013068850A8 (fr) | 2013-10-10 |
| IL232418A0 (en) | 2014-06-30 |
| CA2854591A1 (fr) | 2013-05-16 |
| IL232418A (en) | 2016-10-31 |
| WO2013068850A3 (fr) | 2013-08-22 |
| KR20140089427A (ko) | 2014-07-14 |
| TW201335175A (zh) | 2013-09-01 |
| EP2776449A2 (fr) | 2014-09-17 |
| CN103974964A (zh) | 2014-08-06 |
| KR101756772B1 (ko) | 2017-07-26 |
| AU2012335280A1 (en) | 2014-05-22 |
| TWI488861B (zh) | 2015-06-21 |
| JP2014532690A (ja) | 2014-12-08 |
| EP2776449B1 (fr) | 2017-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN04050A (fr) | ||
| PH12016500739B1 (en) | Inhibitors of the fibrolast growth factor receptor | |
| IN2015DN00127A (fr) | ||
| MX2013008390A (es) | Preparacion de estructuras de metal-triazolato. | |
| PH12016500676B1 (en) | Pyrimidine fgfr4 inhibitors | |
| IN2012DN06714A (fr) | ||
| WO2012158843A3 (fr) | Inhibiteurs de kinase | |
| MX2014002053A (es) | Anticuerpos anti -mcsp y metodos de uso. | |
| UA111186C2 (uk) | Способи та композиції для одержання норибогаїну з воакангіну | |
| MX2015002487A (es) | Proceso para la preparacion de teneligliptina. | |
| EP2729464B8 (fr) | 1,3-thiazépines à cyclopropyle fusionné en tant qu'inhibiteurs de bace 1 et/ou de bace 2 | |
| MX370253B (es) | Composiciones de compuestos de jasmonato y métodos de uso de las mismas. | |
| MX2015001506A (es) | Proceso e intermediarios para preparar inhibidores de integrasa. | |
| IN2013MU00848A (fr) | ||
| IN2014DN09450A (fr) | ||
| IN2014DN06738A (fr) | ||
| EP3302486A4 (fr) | Composés de dihydropyrazolopyrimidinone utilisés comme inhibiteurs de pde2 | |
| IN2014CN00312A (fr) | ||
| EP3294297A4 (fr) | Composés de pyrimidinone amide en tant qu'inhibiteurs de pde2 | |
| WO2012106702A3 (fr) | Traitement de la leucémie | |
| IN2014DN10209A (fr) | ||
| HUE042626T2 (hu) | Eljárások a medetomidin szintézisnél hasznosítható vegyületek, például 3 aril-butiral-dehidek elõállítására | |
| IN2015DN02513A (fr) | ||
| MX369174B (es) | Proceso para la preparación de un compuesto. | |
| EP3291817A4 (fr) | Composés d'hétéroaryl-pyrimidinone en tant qu'inhibiteurs de pde2 |